Amryt Pharma Plc (AMYT) [Rocket]

Amryt Pharma Plc (AMYT)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Price:	$17.38			Metrics
OS:
Market cap:
Net cash:
EV:

TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings (All items)

Date Filed	Type	Description
04/06/2021	GN	Amryt Announces the Appointment of Sheila Frame as President Americas
03/31/2021	GN	Amryt Submits a New Drug Application to the US Food and Drug Administration for Oleogel-S10* (Filsuvez®)
03/29/2021	GN	Amryt Announces Validation of its MAA by the EMA for Oleogel-S10* (Filsuvez®)
03/23/2021	GN	Amryt Receives Positive Feedback from the FDA on the Path Forward for Myalept® (metreleptin) Indication in Partial Lipodystrophy
03/22/2021	GN	Amryt Receives Reimbursement Approval from the French Ministry of Social Affairs and Health for Myalepta® (metreleptin)
03/15/2021	GN	Director/PDMR Shareholding
03/12/2021	GN	Exercise of Options and Total Voting Rights

Revenue Mix by Segment

Financial Summary (All financials)
No report was found.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy